Disrupted Sleep — Patent Landscape
1
Approved drugs
13
Active US patents
43/100
Avg vulnerability
—
Annual revenue covered
Originators in Disrupted Sleep
Cliff calendar — next 15 years
4
32
2
33
6
34
1
37
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Arnicare Leg Cramps
COPPER
|
Sebela Womens Hlth | 13 | 43 | — | 2032-08-14 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 10398588 | Arnicare Leg Cramps | method of use | 58 | 2034-02-24 |
| 9610191 | Arnicare Leg Cramps | method of use | 58 | 2034-02-24 |
| 9265652 | Arnicare Leg Cramps | method of use | 58 | 2034-04-28 |
| 9427351 | Arnicare Leg Cramps | formulation | 38 | 2032-08-14 |
| 10188546 | Arnicare Leg Cramps | formulation | 38 | 2032-08-14 |
| 10159596 | Arnicare Leg Cramps | formulation | 38 | 2032-08-14 |
| 11850181 | Arnicare Leg Cramps | formulation | 38 | 2032-08-14 |
| 9089418 | Arnicare Leg Cramps | formulation | 38 | 2033-04-09 |
| 12138199 | Arnicare Leg Cramps | formulation | 38 | 2033-10-18 |
| 10022264 | Arnicare Leg Cramps | formulation | 38 | 2034-03-22 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 10918516 | Arnicare Leg Cramps | formulation | 38 | 2037-01-23 |
| 11207209 | Arnicare Leg Cramps | formulation | 38 | 2034-08-16 |
| 10166141 | Arnicare Leg Cramps | formulation | 38 | 2034-06-13 |
| 10022264 | Arnicare Leg Cramps | formulation | 38 | 2034-03-22 |
| 12138199 | Arnicare Leg Cramps | formulation | 38 | 2033-10-18 |
| 9089418 | Arnicare Leg Cramps | formulation | 38 | 2033-04-09 |
| 10188546 | Arnicare Leg Cramps | formulation | 38 | 2032-08-14 |
| 10159596 | Arnicare Leg Cramps | formulation | 38 | 2032-08-14 |
| 9427351 | Arnicare Leg Cramps | formulation | 38 | 2032-08-14 |
| 11850181 | Arnicare Leg Cramps | formulation | 38 | 2032-08-14 |
Related
- Disrupted Sleep — full disease profile
- AI Patent Landscape Report — type "disrupted sleep" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner